Chongqing, China

Dajun Li

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dajun Li. Retrieved from https://idiyas.com/inventor/dajun-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 21.5

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dajun Li: Innovator in Polyethylene Glycol Conjugate Drugs

Introduction

Dajun Li is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicine, particularly in the development of polyethylene glycol conjugate drugs. With a total of three patents to his name, his work is paving the way for advancements in pharmaceutical compositions.

Latest Patents

Dajun Li's latest patents include innovative formulations and methods related to polyethylene glycol conjugated drugs. One of his notable inventions is a polyethylene glycol conjugate drug, which includes a preparation method and its various uses. This invention focuses on a specific formula and its pharmaceutically acceptable salts. Another significant patent is for a polyethylene glycol conjugate medicament, which also details a preparation method and its applications in drug formulation. These inventions highlight his expertise in the technical field of medicines.

Career Highlights

Dajun Li is associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to work on groundbreaking research and development in the pharmaceutical sector. His contributions have been instrumental in advancing drug delivery systems and improving therapeutic efficacy.

Collaborations

Dajun Li collaborates with talented individuals such as Gaoquan Li and Qian Zhang. Their combined efforts contribute to the innovative environment at Chongqing Upgra Biotechnology Co., Ltd.

Conclusion

Dajun Li's work in polyethylene glycol conjugate drugs represents a significant advancement in the field of medicine. His patents and ongoing research are set to make a lasting impact on pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…